住院患者醒脑静注射液使用情况调查  

Investigation of Clinical Use of Xingnaojing Injections in Inpatients

作　　者：冯静[1] 

机构地区：[1]武汉大学人民医院药学部,武汉430060

出　　处：《医药导报》2017年第1期84-87,共4页Herald of Medicine

摘　　要：目的调查住院患者醒脑静注射液使用情况,为促进其合理应用提供参考。方法回顾性随机抽查某院2014年1月-2015年6月神经内科186份使用了醒脑静注射液的住院病历,对其用法、用量和用药目的进行统计分析。结果该科醒脑静注射液存在超说明书用药情况,其中超剂量给药占59.7%,单次用药剂量为40 m L占13.4%;溶媒选择不当占49.5%;与西药注射剂配伍使用占54.8%,其中与氯化钾联用占47.8%。结论临床使用醒脑静注射液存在不合理情况,应加强其规范使用管理。Objective To investigate the application of xingnaojing injections（ XNJI） in inpatients and further provide a reference for the rational drug use. Methods The retrospective investigation was carried out by reviewing 186 hospitalization records with XNJI from a certain hospital from January 2014 to June 2015. The usage,dosage,and indication of XNJI were analyzed. Results Unlabeled use of XNJI was found in the neurology department inpatients. 59. 7% inpatients were treated with overdosed XNJI,and 13. 4% were treated with a single drug dose of 40 m L. The inappropriate solvent selection accounted for 49. 5%. Compatibility of XNJI and western medicine injection accounted for 54. 8%. It was also found that XNJI was used together with potassium chloride in clinic（ 47. 8%）. Conclusion There exist some irrational uses of XNJI in clinic,thus the use and management of traditional Chinese medicine injections should be standarized.

关 键 词：醒脑静注射液 合理用药 用药调查 

分 类 号：R286[医药卫生—中药学] R969.3[医药卫生—中医学]